Home Induction of Cryptococcus laurentii α-galactosidase
Article
Licensed
Unlicensed Requires Authentication

Induction of Cryptococcus laurentii α-galactosidase

  • Csilla Mészárosová EMAIL logo , Nadežda Kolarova , Renáta Vadkertiová and Eva Stratilová
Published/Copyright: June 22, 2012
Become an author with De Gruyter Brill

Abstract

The surface activity of Cryptococcus laurentii α-galactosidase can be significantly (up to 80 times) influenced by a carbon source present in a cultivation medium. Induction of this enzyme is stimulated by the presence of saccharides containing bound galactose. The highest activity observed when the cells grew in a lactose medium was probably a consequence of the absence of cleavage products serving as repressors (glucose). This idea is supported by the poor growth of cells in the medium with lactose as the carbon source. The induction of surface α-galactosidase was accompanied by increased activities in cytosole. The membrane fraction also contained this enzyme, but the influence of the carbon source was not proportional. The induction of α-galactosidase may play an important role in galactose metabolism of the genus Cryptococcus with a direct influence on the virulence of these capsular yeasts.

[1] Alexander, R. R., & Griffiths, J. M. (1993). Cell components. In Basic biochemical methods (2nd ed., pp. 234–267). New York, NY, USA: Wiley Liss. Search in Google Scholar

[2] Ankel, H., Ankel, E., Schutzbach, J. S., & Garancis, J. C. (1970). Mannosyl transfer in Cryptococcus laurentii. The Journal of Biological Chemistry, 245, 3945–3955. 10.1016/S0021-9258(18)62940-0Search in Google Scholar

[3] Bartek, P., Kolarova, N., & Capek, P. (2001). Isolation and characterization of glycoproteins from the yeast Cryptococcus laurentii var. laurentii II. Extracellular glycoproteins. Chemical Papers, 55, 261–268. Search in Google Scholar

[4] Bauters, T. G. M., Swinne, D., Boekhout, T., Noens, L., & Nelis, H. J. (2001). Repeated isolation of Cryptococcus laurentii from the oropharynx of an immunocompromized patient. Mycopathologia, 153, 133–135. DOI: 10.1023/a:1014551200 043. http://dx.doi.org/10.1023/A:1014551200043Search in Google Scholar

[5] Bose, I., Reese, A. J., Ory, J. J., Janbon, G., & Doering, T. L. (2003). A yeast under cover: the capsule of Cryptococcus neoformans. Eukaryotic Cell, 2003, 655–663. DOI: 10.1128/ec.2.4.655-663.2003. http://dx.doi.org/10.1128/EC.2.4.655-663.200310.1128/EC.2.4.655-663.2003Search in Google Scholar

[6] Cheng, M. F., Chiou, C. C., Liu, Y. C., Wang, H. Z., & Hsieh, K. S. (2001). Cryptococcus laurentii fungemia in a premature neonate. Journal of Clinical Microbiology, 39, 1608–1611. DOI: 10.1128/jcm.39.4.1608-1611.2001. http://dx.doi.org/10.1128/JCM.39.4.1608-1611.200110.1128/JCM.39.4.1608-1611.2001Search in Google Scholar

[7] Cherniak, R., Morris, L. C., & Meyer, S. A. (1992). Glucuronoxylomannan of Cryptococcus neoformans serotype C: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy. Carbohydrate Research, 225, 331–337. DOI: 10.1016/s0008-6215(00)90505-6. http://dx.doi.org/10.1016/S0008-6215(00)90505-610.1016/S0008-6215(00)90505-6Search in Google Scholar

[8] Cherniak, R., & Sundstrom, J. B. (1994). Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infection and Immunity, 62, 1507–1512. 10.1128/iai.62.5.1507-1512.1994Search in Google Scholar

[9] De Jesus, M., Nicola, A. M., Chow, S. K., Lee, I. R., Nong, S., Specht, C. A., Levitz, S. M., & Casadevall, A. (2010). Glucuronoxylomannan, galactoxylomannan and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans. Virulence, 1, 500–508. DOI: 10.4161/viru.1.6.13451. http://dx.doi.org/10.4161/viru.1.6.1345110.4161/viru.1.6.13451Search in Google Scholar

[10] Doering, T. L. (2000). How does Cryptococcus get its coat? Trends in Microbiology, 8, 547–553. DOI: 10.1016/s0966-842x(00)01890-4. http://dx.doi.org/10.1016/S0966-842X(00)01890-410.1016/S0966-842X(00)01890-4Search in Google Scholar

[11] Dudíková, J., & Kolarova, N. (2006). Extracellular polysaccharides produced by acapsular mutant of Cryptococcus laurentii. Chemical Papers, 60, 69–70. DOI: 10.2478/s11696-006-0013-0. http://dx.doi.org/10.2478/s11696-006-0013-010.2478/s11696-006-0013-0Search in Google Scholar

[12] Garro, M. S., de Valdez, G. F., Oliver, G., & de Giori, G. S. (1996). Influence of carbohydrates on the α-galactosidase activity of Lactobacillus fermentum. Current Microbiology, 33, 302–305. DOI: 10.1007/s002849900118. http://dx.doi.org/10.1007/s00284990011810.1007/s002849900118Search in Google Scholar PubMed

[13] Ibrahim, A. S., Filler, S. G., Alcouloumre, M. S., Kozel, T. R., Edwards, J. E., Jr., & Ghannoum, M. A. (1995). Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: Role of the capsule. Infection and Immunity, 63, 4368–4374. 10.1128/iai.63.11.4368-4374.1995Search in Google Scholar PubMed PubMed Central

[14] Johnson, L. B., Bradley, S. F., & Kauffman, C. A. (1998). Fungaemia due to Cryptococcus laurentii and a review of non-neoformans cryptococcaemia. Mycoses, 41, 277–280. DOI: 10.1111/j.1439-0507.1998.tb00338.x. http://dx.doi.org/10.1111/j.1439-0507.1998.tb00338.x10.1111/j.1439-0507.1998.tb00338.xSearch in Google Scholar PubMed

[15] Khawcharoenporn, T., Apisarnthanarak, A., Kiratisin, P., Mundy, L. M., & Bailey, T. C. (2006). Evaluation of Cryptococcus laurentii meningitis in a patient with HIV infection: A case report and review of the literature. Hawaii Medical Journal, 65, 260–263. Search in Google Scholar

[16] Kolarova, N., Matulová, M., & Capek, P. (1997). Structure of glucomannan-protein from the yeast Cryptococcus laurentii. Journal of Carbohydrate Chemistry, 16, 609–623. DOI: 10.1080/07328309708007339. http://dx.doi.org/10.1080/0732830970800733910.1080/07328309708007339Search in Google Scholar

[17] Kordossis, T., Avlami, A., Velegraki, A., Stefanou, I., Georgakopoulus, G., Papalambrou, C., & Legakis, N. J. (1998). First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients. Medical Mycology, 36, 335–339. DOI: 10.1111/j.1365-280X.1998.00166.x. 10.1111/j.1365-280X.1998.00166.xSearch in Google Scholar

[18] Kwon-Chung, K. J., & Bennett, J. E. (1992). Medical mycology (2nd ed.). Philadelphia, PA, USA: Lea & Febiger. Search in Google Scholar

[19] Levitz, S. M., Nong, S., Mansour, M. K., Huang, C., & Specht, C. A. (2001). Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans. Proceedings of the National Academy of Sciences of the United States of America, 98, 10422–10427. DOI: 10.1073/pnas.181331398. http://dx.doi.org/10.1073/pnas.18133139810.1073/pnas.181331398Search in Google Scholar PubMed PubMed Central

[20] Loftus, B. J., Fung, E., Roncaglia, P., Rowley, D., Amedeo, P., Bruno, D., Vamathevan, J., Miranda, M., Anderson, I. J., Fraser, J. A., Allen, J. E., Bosdet, I. E., Brent, M. R., Chiu, R., Doering, T. L., Donlin, M. J., D’souza, C. A., Fox, D. S., Grinberg, V., Fu, J., Fukushima, M., Haas, B. J., Huang, J. C., Janbon, G., Jones, S. J. M., Koo, H. L., Krzywinski, M. I., Kwon-Chung, J. K., Lengeler, K. B., Maiti, R., Marra, M. A., Marra, R. E., Mathewson, C. A., Mitchell, T. G., Pertea, M., Riggs, F. R., Salzberg, S. L., Schein, J. E., Shvartsbeyn, A., Shin, H., Shumway, M., Specht, C. A., Suh, B. B., Tenney, A., Utterback, T. R., Wickes, B. L., Wortman, J. R., Wye, N. H., Kronstad, J.W., Lodge, J. K., Heitman, J., Davis, R. W., Fraser, C. M., & Hyman, R. W. (2005). The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science, 307, 1321–1324. DOI: 10.1126/science. 1103773. http://dx.doi.org/10.1126/science.110377310.1126/scienceSearch in Google Scholar

[21] Maceková, D., Farkaš, V., Kishida, E., & Takeo, K. (2006). Ectoglycanases and metabolic stability of the capsule in Cryptococcus neoformans. Journal of Basic Microbiology, 46, 470–479. DOI: 10.1002/jobm.200610143. http://dx.doi.org/10.1002/jobm.20061014310.1002/jobm.200610143Search in Google Scholar PubMed

[22] Matulová, M., Kolarova, N., & Capek, P. (2002). An extracellular galactoglucoxylomannan protein from the yeast Cryptococcus laurentii var. laurentii. Journal of Carbohydrate Chemistry, 21, 521–537. DOI: 10.1081/car-120016851. http://dx.doi.org/10.1081/CAR-12001685110.1081/CAR-120016851Search in Google Scholar

[23] McFadden, D. C., & Casadevall, A. (2001). Capsule and melanin synthesis in Cryptococcus neoformans. Medical Mycology, 39, 19–30. DOI: 10.1080/mmy.39.1.19.30. 10.1080/mmy.39.1.19.30Search in Google Scholar

[24] McFadden, D. C., & Casadevall, A. (2004). Unexpected diversity in the fine specificity of monoclonal antibodies that use the same V region gene to glucuronoxylomannan of Cryptococcus neoformans. The Journal of Immunology, 172, 3670–3677. 10.4049/jimmunol.172.6.3670Search in Google Scholar PubMed

[25] McFadden, D. C., De Jesus, M., & Casadevall, A. (2006a). The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction. The Journal of Biological Chemistry, 281, 1868–1875. DOI: 10.1074/jbc.M509465200. http://dx.doi.org/10.1074/jbc.M50946520010.1074/jbc.M509465200Search in Google Scholar PubMed

[26] McFadden, D., Zaragoza, O., & Casadevall, A. (2006b). The capsular dynamics of Cryptococcus neoformans. Trends in Microbiology, 14, 497–505. DOI: 10.1016/j.tim.2006.09.003. http://dx.doi.org/10.1016/j.tim.2006.09.00310.1016/j.tim.2006.09.003Search in Google Scholar PubMed

[27] Mitchell, T. G., & Perfect, J. R. (1995). Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clinical Microbiology Reviews, 8, 515–548. 10.1128/CMR.8.4.515Search in Google Scholar

[28] Moyrand, F., Fontaine, T., & Janbon, G. (2007). Systematic capsule gene disruption reveales the central role of galactose metabolism on Cryptococcus neoformance virulence. Molecular Microbiology, 64, 771–781. DOI: 10.1111/j.1365-2958.2007.05695.x. http://dx.doi.org/10.1111/j.1365-2958.2007.05695.x10.1111/j.1365-2958.2007.05695.xSearch in Google Scholar

[29] Perfect, J. R., & Casadevall, A. (2002). Cryptococcosis. Infectious Disease Clinics of North America, 16, 837–874. http://dx.doi.org/10.1016/S0891-5520(02)00036-310.1016/S0891-5520(02)00036-3Search in Google Scholar

[30] Pirofski, L. A., & Casadevall, A. (1996). Cryptococcus neoformans: Paradigm for the role of antibody immunity against fungi? Zentralblatt für Bakteriologie, 284, 475–495. DOI: 10.1016/s0934-8840(96)80001-6. http://dx.doi.org/10.1016/S0934-8840(96)80001-610.1016/S0934-8840(96)80001-6Search in Google Scholar

[31] Reiss, E., Huppert, M., & Cherniak, R. (1985). Characterization of protein and mannan polysaccharide antigens of yeasts, moulds, and actinomycetes. Current Topics in Medical Mycology, 1, 172–207. http://dx.doi.org/10.1007/978-1-4613-9547-8_710.1007/978-1-4613-9547-8_7Search in Google Scholar

[32] Schutzbach, J., Ankel, H., & Brockhausen, I. (2007). Synthesis of cell envelope glycoproteins of Cryptococcus laurentii. Carbohydrate Research, 342, 881–893. DOI: 10.1016/j.carres. 2007.01.002. http://dx.doi.org/10.1016/j.carres.2007.01.00210.1016/j.carres.2007.01.002Search in Google Scholar

[33] Shankar, E. M., Kumarasamy, N., Bella, D., Renuka, S., Kownhar, H., Suniti, S., Rajan, R., & Rao, U. A. (2006). Pneumonia and pleural effusion due to Cryptococcus laurentii in a clinically proven case of AIDS. Canadian Respiratory Journal, 13, 275–278. 10.1155/2006/160451Search in Google Scholar

[34] Sugita, T., Takashima, M., Ikeda, R., Nakase, T., & Shinoda, T. (2000). Intraspecies diversity of Cryptococcus laurentii as revealed by sequences of internal transcribed spacer regions and 28S rRNA gene and taxonomic position of C. laurentii clinical isolates. Journal of Clinical Microbiology, 38, 1468–1471. 10.1128/JCM.38.4.1468-1471.2000Search in Google Scholar

[35] Vaishnav, V. V., Bacon, B. E., O’Neill, M., & Cherniak, R. (1998). Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67. Carbohydrate Research, 306, 315–330. DOI: 10.1016/s0008-6215(97)10058-1. http://dx.doi.org/10.1016/S0008-6215(97)10058-110.1016/S0008-6215(97)10058-1Search in Google Scholar

[36] Van Schaftingen, E. (1989). A protein from rat liver confers to glucokinase the property of being antagonistically regulated by fructose 6-phosphate and fructose 1-phosphate. European Journal of Biochemistry, 179, 179–184. DOI: 10.1111/j.1432-1033.1989.tb14538.x. http://dx.doi.org/10.1111/j.1432-1033.1989.tb14538.x10.1111/j.1432-1033.1989.tb14538.xSearch in Google Scholar PubMed

[37] Yanagisawa, K., Resnick, D., Abeijon, C., Robbins, P. W., & Hirschberg, C. B. (1990). A guanosine diphosphatase enriched in Golgi vesicles of Saccharomyces cerevisiae. Purification and characterization. The Journal of Biological Chemistry, 265, 19351–19355. 10.1016/S0021-9258(17)30665-8Search in Google Scholar

[38] Zaragoza, O., Rodrigues, M. L., De Jesus, M., Frases, S., Dadachova, E., & Casadevall, A. (2009). The capsule of the fungal pathogen Cryptococcus neoformans. Advances in Applied Microbiology, 68, 133–216. DOI: 10.1016/s0065-2164(09)01204-0. http://dx.doi.org/10.1016/S0065-2164(09)01204-010.1016/S0065-2164(09)01204-0Search in Google Scholar

[39] Zaragoza, O., Telzak, A., Bryan, R. A., Dadachova, E., & Casadevall, A. (2006). The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding. Molecular Microbiology, 59, 67–83. DOI: 10.1111/j.1365-2958.2005.04928.x. http://dx.doi.org/10.1111/j.1365-2958.2005.04928.x10.1111/j.1365-2958.2005.04928.xSearch in Google Scholar PubMed

Published Online: 2012-6-22
Published in Print: 2012-9-1

© 2012 Institute of Chemistry, Slovak Academy of Sciences

Downloaded on 27.11.2025 from https://www.degruyterbrill.com/document/doi/10.2478/s11696-012-0170-2/pdf
Scroll to top button